Ograniczenia Genetyczne w Sporcie

Dla bardziej zainteresowanych !!!!!!

Jamie has spent time in both academic (11yr) and industrial (8yr) research settings. During this time in academia he has published over 80 original articles, book chapters and patents including articles in J Clinical Investigation, FASEB Journal, Diabetes, Genome Medicine, J Applied Physiology, J Biological Chemistry and Proceedings of the National Academy of Sciences USA (the majority as first or senior author).

His work is currently featured in a BBC Horizon programme (2012) on the science behind physical activity and exercise.

Applying Systems Biology to a broad range of medical topics, his lab has generated a number of firsts in human physiology and metabolic research including the first genomic predictor of physiological adaptation in humans in 2010 and the discovery of the adipo-myocyte in 2006. Since returning to the UK in 2006 he has raised >L9M for medical research. Jamie's lab recently developed the first accurate multi-organ predictor of age in humans.

A graduate of the University of Glasgow in 1993, Jamie completed a PhD in muscle physiology and metabolism at the University of Nottingham in May 1996 during which time he was awarded the European Young Investigator of the Year 2006 by the European College for Sports Medicine and Science. He spent 8 years working within the Pharmaceutical industry as a Team Leader in Lead identification and Lead development projects and was involved with the nomination of drug candidates for the treatment of cardiovascular disease. In 1999, while at Pfizer, he started arguably one of the first “translational medicine” projects, which was aimed at better understanding human muscle diseases. A data-base of muscle phenotypes and gene-chip profiles (in collaboration with the Karolinska Institute and Affymetrix) has been built over the following decade and a number of predictors of clinical response has been generated

In 2003 he moved to the Karolinska Institute, and worked at the Centre for Genomics and Bioinformatics as a team leader with Prof Claes Wahlestedt. Here he developed an interest in non-coding RNA molecules and linking gene regulation to physiological heterogeneity in humans. Since then he has studies both coding RNA and microRNA changes in the areas of muscle and adipocyte biology and discovered novel markers of tissue plasticity.

In 2006 he was appointed Chair of Exercise Biology and Director of the Sports and Exercise Degree Program, at Heriot-Watt University Edinburgh. While acting as Director of Research and over-seeing the RAE2008 Department of Biology return and the restructuring of the University Biology activities ( http://www.hw.ac.uk/reference/focus-on-the-future.pdf), Jamie expanded his translational medicine projects to cover diabetes, cancer-cachexia and develop novel approaches to studying human ‘exercise resistance’.

In 2009 he was awarded the American College of Sports Medicine and European College of Sports Science Prize Exchange Lecture in Seattle and Olso. Odpowiedz